Immunology
-
Modeling predicts mechanisms altered by mutations of the SARS-CoV-2 delta and omicron variants
This article has 8 authors:Reviewed by ScreenIT
-
Pre-clinical testing of two serologically distinct chimpanzee-origin adenovirus vectors expressing spike of SARS-CoV-2
This article has 9 authors:Reviewed by ScreenIT
-
A SARS-CoV-2 peptide vaccine which elicits T-cell responses in mice but does not protect against infection or disease
This article has 15 authors:Reviewed by ScreenIT
-
Mucosal Immunization of Cynomolgus Macaques with Adenoviral Vector Vaccine Elicits Neutralizing Nasal and Serum Antibody to Several SARS-CoV-2 Variants
This article has 10 authors:Reviewed by ScreenIT
-
SARS-CoV-2 Variant Delta Potently Suppresses Innate Immune Response and Evades Interferon-Activated Antiviral Responses
This article has 8 authors:Reviewed by ScreenIT
-
Omicron Booster in Ancestral Strain Vaccinated Mice Augments Protective Immunities Against Both Delta and Omicron Variants
This article has 9 authors:Reviewed by ScreenIT
-
Alterations in SARS-CoV-2 Omicron and Delta peptides presentation by HLA molecules
This article has 10 authors:Reviewed by ScreenIT
-
SARS-CoV-2 Viroporins Activate The NLRP3-Inflammasome Via The Mitochondrial Permeability Transition Pore
This article has 6 authors:Reviewed by ScreenIT
-
Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine
This article has 38 authors:Reviewed by ScreenIT
-
A novel intranasal administration adenoviral vector-based platform for rapid COVID-19 vaccine development
This article has 14 authors:Reviewed by ScreenIT